CRP and endothelial dysfunction: Cytokines showed synergic role when combined to a classic biomarker of systemic inflammation (CRP) and to an emerging marker of endothelial dysfunction (MR-proADM) and may have additive effect to better explain disease pathogenesis and suggest more targeted intervention.